REDWOOD CITY, Calif.--(BUSINESS WIRE)--Satoris, Inc., a California-based molecular diagnostics company, announced today the launch of three research-use tests – two panels of plasma biomarkers shown to be significant in the neurodegenerative disease process, and a dementia discrimination panel. Specifically for use by Alzheimer’s researchers and by pharmaceutical companies developing new Alzheimer’s therapies, the panels are available now as a testing service.